Adjuvants influence the quantitative and qualitative immune response in BALBc mice immunized with respiratory syncytial virus FG subunit vaccine

This publication has 18 references indexed in Scilit:

• Effect of Adjuvants on Immunogenicity of MN Recombinant Glycoprotein 120 in Guinea Pigs
  AIDS Research and Human Retroviruses, 1995
• Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in mice that are similar to those generated by experimental infection
  Vaccine, 1995
• Monophosphoryl lipid A enhances specific CTL induction by a soluble protein antigen entrapped in liposomes
  Vaccine, 1993
• Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.
  Journal of Clinical Investigation, 1991
• Reinfection of mice with respiratory syncytial virus
  Journal of Medical Virology, 1991
• Characterization of a Novel Human Respiratory Syncytial Virus Chimeric FG Glycoprotein Expressed Using a Baculovirus Vector
  Journal of General Virology, 1989
• Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.
  The Journal of Experimental Medicine, 1989
• Primary respiratory syncytial virus infection in mice
  Journal of Medical Virology, 1988
• Parenteral Administration of Live Respiratory Syncytial Virus Vaccine: Results of a Field Trial
  The Journal of Infectious Diseases, 1982
• Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants
  The Journal of Pediatrics, 1976